Business Insider18 天
Auron Presents New Preclinical Data for AUTX-703 in AML at ASH Annual Meeting
Data demonstrate dose dependent survival advantage with AUTX-703 in primary patient-derived orthotopic AML model IND submissions on track for late 2024 NEWTON, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- ...